Thomas Ciulla

Position	Company	Period
Chief Medical Officer	Clearside Biomedical Inc	Oct. 1, 2018 - Dec. 31, 2018

• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings

Download results Settings

Clearside Biomedical Inc (CLSD)

Transaction date 20 Jan 2023

Planned sale

Price

250.16

Quantity 64,485 -37.6%

Value US$1,867,900

Comments Filing

Clearside Biomedical Inc (CLSD)

Transaction date 10 Jan 2023

Planned sale

Price

259.99

Quantity 2,544 -5.6%

Value US$370,752

Comments Filing

Clearside Biomedical Inc (CLSD)

Transaction date 19 Jan 2022

Planned sale

Price

67.24

Quantity 63,803 +37.7%

Value US$1,660,702

Comments Filing

Notification date	Transaction date	Company	B/S Transaction type	Nb. shares Price Value	Number of shares	Price	Value
2023-01-20	2023-01-20	Clearside Biomedical Inc (CLSD)	PlS Planned sale	64,485 -37.6% 250.16 US$1,867,900	64,485 -37.6%	250.16	US$1,867,900
2023-01-11	2023-01-10	Clearside Biomedical Inc (CLSD)	PlS Planned sale	2,544 -5.6% 259.99 US$370,752	2,544 -5.6%	259.99	US$370,752
2022-01-20	2022-01-19	Clearside Biomedical Inc (CLSD)	PlS Planned sale	63,803 +37.7% 67.24 US$1,660,702	63,803 +37.7%	67.24	US$1,660,702